The Pediatric Device Initiative (PDI) has built a grassroots consortium of physicians, scientists, engineers, and commercial partners to accelerate development and translation of novel pediatric technologies. In collaboration with the McGowan Institute for Regenerative Medicine and Children’s Hospital of Pittsburgh of UPMC (CHP), sciVelo has developed a portfolio of over 40 technology opportunities across more than a dozen pediatric clinical subspecialties. Furthermore, sciVelo has established new collaborations, between CHP clinicians and scientists/engineers at the McGowan Institute, to innovate new tissue & organ regeneration therapies, medical devices, and surgical tools.
“sciVelo has been an instrumental part of accelerating the outcomes of the Pediatric Device Initiative. Their experienced principals and commitment to the project have been an enormous asset to McGowan and we look forward to continuing our partnership with them in the future.”
Patrick Cantini, University of Pittsburgh, McGowan Institute
These collaborations have resulted in the development of seven early-stage pediatric pilot projects directly funded by the PDI, including: extracellular matrix (ECM) technology for esophageal repair, a ventriculoamniotic shunt for the treatment of fetal hydrocephalus, and biodegradable stents to prevent airway obstruction in infants, among others.
sciVelo’s work with PDI culminated in launching the inaugural Pediatric Innovation Retreat at the University of Pittsburgh, which brought together thought leaders from across Pittsburgh and the nation to discuss challenges and opportunities in developing and commercializing novel pediatric technologies.
sciVelo continues to build a robust pediatric technology ecosystem at the University of Pittsburgh, leveraging local and national commercialization resources to establish Pittsburgh as a national hub for pediatric technology commercialization.